Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,668,746
-$7,827,109 QoQ
Shares Held
370,898
-40.1% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Derivatives in URGN
reported options exposure · as of Sep 30, 2025CallValue
$897,750
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,468,729,571 across 342 Biotechnology names. URGN ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in URGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,668,746 | 370,898 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,495,855 | 618,952 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,301,303 | 1,468,737 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $897,750 | 45,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $615,130 | 44,900 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $8,138,224 | 594,031 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,684,850 | 423,585 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,877,610 | 645,785 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,039,852 | 1,499,201 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,479,885 | 1,160,899 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $628,200 | 41,880 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,397,590 | 426,506 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,863,747 | 275,785 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,988,524 | 192,128 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,278,130 | 354,776 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,459,189 | 277,248 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,656,823 | 439,522 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,047,046 | 616,245 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,366,633 | 156,904 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $641,848 | 67,492 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,155,315 | 68,687 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $974,226 | 63,800 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,445,435 | 74,201 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,288,826 | 71,522 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,730,467 | 89,708 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,776,007 | 106,279 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||